Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Effectiveness of the combination of vascular targeted photodynamic therapy and anti-cytotoxic T-lymphocyte-associated antigen 4 in a preclinical mouse model of urothelial carcinoma.

Corradi RB, LaRosa S, Jebiwott S, Murray KS, Rosenzweig B, Somma AJ, Gomez RS, Scherz A, Kim K, Coleman JA.

Int J Urol. 2019 Jan 18. doi: 10.1111/iju.13878. [Epub ahead of print]

PMID:
30659668
2.

Examination of Racial Differences in a Posttraumatic Stress Disorder Group Therapy Program for Veterans.

Coleman JA, Lynch JR, Ingram KM, Sheerin CM, Rappaport LM, Trapp SK.

Group Dyn. 2018 Sep;22(3):129-142. doi: 10.1037/gdn0000086. Epub 2018 Jul 19.

PMID:
30505143
3.

That's No Bee Sting: Penetrating Neck Trauma with Isolated Vertebral Artery Injury.

Rountree KM, Zachwieja JA, Coleman JA, Hinton IJ, Lopez PP.

Am Surg. 2018 Sep 1;84(9):e431-e433. No abstract available.

PMID:
30454525
4.

Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.

Audenet F, Isharwal S, Cha EK, Donoghue MTA, Drill EN, Ostrovnaya I, Pietzak EJ, Sfakianos JP, Bagrodia A, Murugan P, Dalbagni G, Donahue TF, Rosenberg JE, Bajorin DF, Arcila ME, Hechtman JF, Berger MF, Taylor BS, Al-Ahmadie H, Iyer G, Bochner BH, Coleman JA, Solit DB.

Clin Cancer Res. 2019 Feb 1;25(3):967-976. doi: 10.1158/1078-0432.CCR-18-2039. Epub 2018 Oct 23.

PMID:
30352907
5.

That's No Bee Sting: Penetrating Neck Trauma with Isolated Vertebral Artery Injury.

Rountree KM, Zachwieja JA, Coleman JA, Hinton IJ, Lopez PP.

Am Surg. 2018 Sep 1;84(9):e431-e433. No abstract available.

PMID:
30269734
6.

Proteomic Analysis and Functional Characterization of P4-ATPase Phospholipid Flippases from Murine Tissues.

Wang J, Molday LL, Hii T, Coleman JA, Wen T, Andersen JP, Molday RS.

Sci Rep. 2018 Jul 17;8(1):10795. doi: 10.1038/s41598-018-29108-z.

7.

Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.

Carlo MI, Mukherjee S, Mandelker D, Vijai J, Kemel Y, Zhang L, Knezevic A, Patil S, Ceyhan-Birsoy O, Huang KC, Redzematovic A, Coskey DT, Stewart C, Pradhan N, Arnold AG, Hakimi AA, Chen YB, Coleman JA, Hyman DM, Ladanyi M, Cadoo KA, Walsh MF, Stadler ZK, Lee CH, Feldman DR, Voss MH, Robson M, Motzer RJ, Offit K.

JAMA Oncol. 2018 Sep 1;4(9):1228-1235. doi: 10.1001/jamaoncol.2018.1986.

PMID:
29978187
8.

Moderation of improvement in self-efficacy following group psychotherapy for PTSD.

Cusack SE, Coleman JA, Rappaport LM, Sheerin C.

Psychol Serv. 2018 Jul 2. doi: 10.1037/ser0000260. [Epub ahead of print]

PMID:
29963876
9.

The association of renal cell carcinoma with gastrointestinal stromal tumors.

Mendonca SJ, Sanchez A, Blum KA, Ghanaat M, Kashan MY, Benfante N, Russo P, Coleman JA, Crago AM, Hakimi AA.

J Surg Oncol. 2018 Jun;117(8):1716-1720. doi: 10.1002/jso.25080. Epub 2018 Jun 7.

PMID:
29878354
10.

Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.

Gill IS, Azzouzi AR, Emberton M, Coleman JA, Coeytaux E, Scherz A, Scardino PT; PCM301 Study Group.

J Urol. 2018 Oct;200(4):786-793. doi: 10.1016/j.juro.2018.05.121. Epub 2018 Jun 2.

PMID:
29864437
11.

Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.

Bochner BH, Dalbagni G, Marzouk KH, Sjoberg DD, Lee J, Donat SM, Coleman JA, Vickers A, Herr HW, Laudone VP.

Eur Urol. 2018 Oct;74(4):465-471. doi: 10.1016/j.eururo.2018.04.030. Epub 2018 May 18.

PMID:
29784190
12.

Misclassification of Upper Tract Urothelial Carcinoma in Patients With Lynch Syndrome.

Matin SF, Coleman JA.

JAMA Oncol. 2018 Jul 1;4(7):1010. doi: 10.1001/jamaoncol.2018.0539. No abstract available.

PMID:
29710233
13.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.

Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, Bergren SK, Pietzak EJ, Anderson CB, Benson MC, Coleman JA, Taylor BS, Abate-Shen C, McKiernan JM, Al-Ahmadie H, Solit DB, Shen MM.

Cell. 2018 Apr 5;173(2):515-528.e17. doi: 10.1016/j.cell.2018.03.017.

PMID:
29625057
14.

Pirfenidone inhibits cryoablation induced local macrophage infiltration along with its associated TGFb1 expression and serum cytokine level in a mouse model.

Gu Y, Srimathveeravalli G, Cai L, Ueshima E, Maybody M, Yarmohammadi H, Zhu YS, Durack JC, Solomon SB, Coleman JA, Erinjeri JP.

Cryobiology. 2018 Jun;82:106-111. doi: 10.1016/j.cryobiol.2018.03.012. Epub 2018 Apr 3.

PMID:
29621494
15.

Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.

Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra MF, Manley BJ, Casuscelli J, Chiok M, Coleman JA, Russo P, Tickoo SK, Akin O, Hakimi AA.

J Urol. 2018 Aug;200(2):275-282. doi: 10.1016/j.juro.2018.02.3087. Epub 2018 Mar 1.

PMID:
29496470
16.

Importance of wide re-resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution.

Murray KS, Vertosick EA, Spaliviero M, Mashni JW Jr, Sjoberg DD, Alektiar KM, Herr HW, Russo P, Coleman JA.

J Surg Oncol. 2018 Jun;117(7):1464-1468. doi: 10.1002/jso.25016. Epub 2018 Feb 23.

PMID:
29473967
17.

Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy.

Murray KS, Akin O, Coleman JA.

Rev Urol. 2017;19(4):268-272. doi: 10.3909/riu0755. Review.

18.

Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.

Kim K, Watson PA, Lebdai S, Jebiwott S, Somma AJ, La Rosa S, Mehta D, Murray KS, Lilja H, Ulmert D, Monette S, Scherz A, Coleman JA.

Clin Cancer Res. 2018 May 15;24(10):2408-2416. doi: 10.1158/1078-0432.CCR-17-3474. Epub 2018 Feb 20.

PMID:
29463549
19.

Genomic Profile of Urothelial Carcinoma of the Upper Tract from Ureteroscopic Biopsy: Feasibility and Validation Using Matched Radical Nephroureterectomy Specimens.

Bagrodia A, Audenet F, Pietzak EJ, Kim K, Murray KS, Cha EK, Sfakianos JP, Iyer G, Singla N, Arcila M, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA.

Eur Urol Focus. 2018 Jan 30. pii: S2405-4569(18)30006-3. doi: 10.1016/j.euf.2018.01.005. [Epub ahead of print]

PMID:
29396293
20.

Structural basis for recognition of diverse antidepressants by the human serotonin transporter.

Coleman JA, Gouaux E.

Nat Struct Mol Biol. 2018 Feb;25(2):170-175. doi: 10.1038/s41594-018-0026-8. Epub 2018 Jan 29.

21.

Timing of blood transfusion and oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.

Bagrodia A, Kaffenberger S, Winer A, Murray K, Vacchio M, Zheng J, Ostrovnaya I, Bochner BH, Dalbagni G, Cha EK, Coleman JA.

World J Urol. 2018 Apr;36(4):645-653. doi: 10.1007/s00345-018-2180-3. Epub 2018 Jan 17.

PMID:
29344681
22.

WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice.

Neuschmelting V, Kim K, Malekzadeh-Najafabadi J, Jebiwott S, Prakash J, Scherz A, Coleman JA, Kircher MF, Ntziachristos V.

Theranostics. 2018 Jan 1;8(3):723-734. doi: 10.7150/thno.20386. eCollection 2018.

23.

The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy.

Winer AG, Zabor EC, Vacchio MJ, Hakimi AA, Russo P, Coleman JA, Jaimes EA.

Clin Genitourin Cancer. 2018 Jun;16(3):191-196. doi: 10.1016/j.clgc.2017.11.006. Epub 2017 Dec 6.

PMID:
29325738
24.

Negative Interpersonal Interactions and Dating Abuse Perpetration: The Mediating Role of Dispositional Forgivingness.

Garthe RC, Griffin BJ, Worthington EL Jr, Goncy EA, Sullivan TN, Coleman JA, Davis DE, Kwakye-Nuako CO, Mokushane T, Makola S, Anakwah N.

J Interpers Violence. 2018 Aug;33(15):2311-2334. doi: 10.1177/0886260517714438. Epub 2017 Jun 14.

PMID:
29294787
25.

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma.

Lee BH, Zabor EC, Tennenbaum D, Furberg H, Benfante N, Coleman JA, Jaimes EA, Russo P.

World J Urol. 2018 Feb;36(2):257-263. doi: 10.1007/s00345-017-2139-9. Epub 2017 Dec 5.

26.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.

Becerra MF, Reznik E, Redzematovic A, Tennenbaum DM, Kashan M, Ghanaat M, Casuscelli J, Manley B, Jonsson P, DiNatale RG, Blum KA, Durack JC, Solomon SB, Arcila ME, Bourque C, Socci N, Carlo MI, Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, Hsieh JJ.

Eur Urol Focus. 2018 Dec;4(6):986-994. doi: 10.1016/j.euf.2017.09.016. Epub 2017 Oct 20.

PMID:
29066084
27.

Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors.

O'Shaughnessy MJ, Murray KS, La Rosa SP, Budhu S, Merghoub T, Somma A, Monette S, Kim K, Corradi RB, Scherz A, Coleman JA.

Clin Cancer Res. 2018 Feb 1;24(3):592-599. doi: 10.1158/1078-0432.CCR-17-0186. Epub 2017 Sep 27.

28.

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.

Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA.

Eur Urol Focus. 2017 Sep 23. pii: S2405-4569(17)30212-2. doi: 10.1016/j.euf.2017.09.008. [Epub ahead of print]

PMID:
28951115
29.

Contrast enhanced ultrasound imaging can predict vascular-targeted photodynamic therapy induced tumor necrosis in small animals.

Cornelis FH, Kim K, Durack JC, Jebiwott S, Scherz A, Srimathveeravalli G, Coleman JA.

Photodiagnosis Photodyn Ther. 2017 Dec;20:165-168. doi: 10.1016/j.pdpdt.2017.09.002. Epub 2017 Sep 5.

30.

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A, Pradhan N, Arnold A, Walsh MF, Li Y, Balakrishnan AR, Syed A, Prasad M, Nafa K, Carlo MI, Cadoo KA, Sheehan M, Fleischut MH, Salo-Mullen E, Trottier M, Lipkin SM, Lincoln A, Mukherjee S, Ravichandran V, Cambria R, Galle J, Abida W, Arcila ME, Benayed R, Shah R, Yu K, Bajorin DF, Coleman JA, Leach SD, Lowery MA, Garcia-Aguilar J, Kantoff PW, Sawyers CL, Dickler MN, Saltz L, Motzer RJ, O'Reilly EM, Scher HI, Baselga J, Klimstra DS, Solit DB, Hyman DM, Berger MF, Ladanyi M, Robson ME, Offit K.

JAMA. 2017 Sep 5;318(9):825-835. doi: 10.1001/jama.2017.11137. Erratum in: JAMA. 2018 Dec 11;320(22):2381.

31.

Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.

Nandin IS, Fong C, Deantonio C, Torreno-Pina JA, Pecetta S, Maldonado P, Gasparrini F, Ordovas-Montanes J, Kazer SW, Kjaer S, Borley DW, Nair U, Coleman JA, Lingwood D, Shalek AK, Meffre E, Poignard P, Burton DR, Batista FD.

J Exp Med. 2017 Sep 4;214(9):2811. doi: 10.1084/jem.2017063307262017c. Epub 2017 Aug 21. No abstract available.

32.

Biopsy of Small Renal Masses Should be Routinely Performed before Deciding Treatment: Con.

Coleman JA.

J Urol. 2017 Oct;198(4):757-759. doi: 10.1016/j.juro.2017.07.044. Epub 2017 Aug 18. No abstract available.

PMID:
28826634
33.

Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial.

Spaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, Wren J, Russo P, Coleman JA.

Eur Urol. 2018 Jan;73(1):53-59. doi: 10.1016/j.eururo.2017.07.038. Epub 2017 Aug 16.

PMID:
28822586
34.

Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.

Dong Y, Manley BJ, Becerra MF, Redzematovic A, Casuscelli J, Tennenbaum DM, Reznik E, Han S, Benfante N, Chen YB, Arcila ME, Aras O, Voss MH, Feldman DR, Motzer RJ, Fabbri N, Healey JH, Boland PJ, Chawla M, Durack JC, Lee CH, Coleman JA, Russo P, Hakimi AA, Cheng EH, Hsieh JJ.

Eur Urol Focus. 2017 Dec;3(6):590-598. doi: 10.1016/j.euf.2016.08.005. Epub 2016 Aug 25.

35.

Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.

Manley BJ, Zabor EC, Casuscelli J, Tennenbaum DM, Redzematovic A, Becerra MF, Benfante N, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Ogawa S, Arcila ME, Voss MH, Feldman DR, Coleman JA, Reuter VE, Motzer RJ, Russo P, Hsieh JJ, Hakimi AA.

Eur Urol Focus. 2017 Oct;3(4-5):421-427. doi: 10.1016/j.euf.2016.06.015. Epub 2016 Jul 16.

36.

Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.

Sanjuan Nandin I, Fong C, Deantonio C, Torreno-Pina JA, Pecetta S, Maldonado P, Gasparrini F, Ordovas-Montanes J, Kazer SW, Kjaer S, Borley DW, Nair U, Coleman JA, Lingwood D, Shalek AK, Meffre E, Poignard P, Burton DR, Batista FD.

J Exp Med. 2017 Jul 24. pii: jem.20170633. doi: 10.1084/jem.20170633. [Epub ahead of print] Erratum in: J Exp Med. 2017 Aug 21;:.

37.

Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients.

Rosenzweig B, Rubinstein ND, Reznik E, Shingarev R, Juluru K, Akin O, Hsieh JJ, Jaimes EA, Russo P, Susztak K, Coleman JA, Hakimi AA.

PLoS One. 2017 Jul 20;12(7):e0180350. doi: 10.1371/journal.pone.0180350. eCollection 2017.

38.

Nephrometry scores and perioperative outcomes following robotic partial nephrectomy.

Corradi RB, Vertosick EA, Nguyen DP, Vilaseca A, Sjoberg DD, Benfante N, Nogueira LN, Spaliviero M, Touijer KA, Russo P, Coleman JA.

Int Braz J Urol. 2017 Nov-Dec;43(6):1075-1083. doi: 10.1590/S1677-5538.IBJU.2016.0571.

39.

A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.

Cornelis FH, Durack JC, Kimm SY, Wimmer T, Coleman JA, Solomon SB, Srimathveeravalli G.

Cardiovasc Intervent Radiol. 2017 Oct;40(10):1600-1608. doi: 10.1007/s00270-017-1692-3. Epub 2017 May 17.

40.

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.

Sinha R, Winer AG, Chevinsky M, Jakubowski C, Chen YB, Dong Y, Tickoo SK, Reuter VE, Russo P, Coleman JA, Sander C, Hsieh JJ, Hakimi AA.

Nat Commun. 2017 May 10;8:15165. doi: 10.1038/ncomms15165.

41.

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.

Tennenbaum DM, Manley BJ, Zabor E, Becerra MF, Carlo MI, Casuscelli J, Redzematovic A, Khan N, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Benfante NE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA.

Urol Oncol. 2017 Aug;35(8):532.e7-532.e13. doi: 10.1016/j.urolonc.2017.03.015. Epub 2017 Apr 10.

42.

Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days.

Srimathveeravalli G, Cornelis F, Wimmer T, Monette S, Kimm SY, Maybody M, Solomon SB, Coleman JA, Durack JC.

J Vasc Interv Radiol. 2017 Jun;28(6):913-919.e1. doi: 10.1016/j.jvir.2017.02.032. Epub 2017 Mar 30.

43.

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.

Tay KJ, Scheltema MJ, Ahmed HU, Barret E, Coleman JA, Dominguez-Escrig J, Ghai S, Huang J, Jones JS, Klotz LH, Robertson CN, Sanchez-Salas R, Scionti S, Sivaraman A, de la Rosette J, Polascik TJ.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):294-299. doi: 10.1038/pcan.2017.8. Epub 2017 Mar 28.

44.

A multi-level modeling approach examining PTSD symptom reduction during prolonged exposure therapy: moderating effects of number of trauma types experienced, having an HIV-related index trauma, and years since HIV diagnosis among HIV-positive adults.

Junglen AG, Smith BC, Coleman JA, Pacella ML, Boarts JM, Jones T, Feeny NC, Ciesla JA, Delahanty DL.

AIDS Care. 2017 Nov;29(11):1391-1398. doi: 10.1080/09540121.2017.1300625. Epub 2017 Mar 7.

PMID:
28266223
45.

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.

Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A, Weinhold N, Lee W, Manley BJ, Khalil DN, Kaffenberger SD, Chen Y, Danilova L, Voss MH, Coleman JA, Russo P, Reuter VE, Chan TA, Cheng EH, Scheinberg DA, Li MO, Choueiri TK, Hsieh JJ, Sander C, Hakimi AA.

Genome Biol. 2017 Mar 1;18(1):46. doi: 10.1186/s13059-017-1180-8. No abstract available.

46.

Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.

Kopp RP, Stratton KL, Glogowski E, Schrader KA, Rau-Murthy R, Russo P, Coleman JA, Offit K.

Cancer. 2017 Jul 1;123(13):2452-2458. doi: 10.1002/cncr.30605. Epub 2017 Feb 7.

47.

Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract.

Zareba P, Rosenzweig B, Winer AG, Coleman JA.

Cancer. 2017 May 15;123(10):1741-1750. doi: 10.1002/cncr.30516. Epub 2017 Feb 2.

48.

Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy.

Kim K, Zhang H, La Rosa S, Jebiwott S, Desai P, Kimm S, Scherz A, O'Donoghue JA, Weber WA, Coleman JA.

Clin Cancer Res. 2017 Jul 1;23(13):3343-3351. doi: 10.1158/1078-0432.CCR-16-2745. Epub 2017 Jan 20.

49.

Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.

Winer AG, Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD, Sankin AI, Sfakianos JP, Cha EK, Dalbagni G, Coleman JA.

Urol Oncol. 2017 Apr;35(4):151.e9-151.e15. doi: 10.1016/j.urolonc.2016.11.002. Epub 2016 Dec 5.

50.

Supplemental Content

Loading ...
Support Center